A genetically engineered smallpox vaccine improved the survival of liver cancer patients participating in a phase II clinical trial.
The Scientist
Most Recent
The story of the US government’s efforts to stamp out smallpox in the early 20th century offers insights into the science and practice of mass vaccination.
In Chapter 5, "The Stable and the Laboratory," author Michael Willrich explores the burgeoning vaccine manufacture industry that ramped up to combat smallpox epidemics in turn-of-the-twentieth-century American cities.
The World Health Organization is remaining mum on the issue of maintaining laboratory stocks of the smallpox virus, which the US government wants to preserve for the next five years. The WHO originally slated the two remaining stocks, one at the C
Page 1 of 1
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
